Circulating concentrations of insulin-like growth factor I and risk of breast cancer
- 1 May 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 351 (9113), 1393-1396
- https://doi.org/10.1016/s0140-6736(97)10384-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at termEarly Human Development, 1996
- Alcohol, Height, and Adiposity in Relation to Estrogen and Prolactin Levels in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1995
- Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancerInternational Journal of Cancer, 1995
- Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancerEuropean Journal Of Cancer, 1993
- Evidence of prenatal influences on breast cancer riskThe Lancet, 1992
- High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of miceThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Cell Proliferation in CarcinogenesisScience, 1990
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.Journal of Clinical Investigation, 1989
- Serum, pituitary and urine concentrations of prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumorsInternational Journal of Cancer, 1979